ED vs PMCB · P/E 18, rev $15.26B vs $8.6M cap
Consolidated Edison Inc (ED) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the ED and PMCB stock pages for the full models.
Not investment advice.